| Features and Benefits |
- Do not administer without diluting
- For Intravesical use only
- Not for intramuscular or intravenous use
|
- The dose for the intravesical treatment of carcinoma in situ and for the prophylaxis of recurrent papillary tumors consists of one vial of TICE® BCG suspended in 50 ml preservative-free saline
- Intravesical TICE® BCG has been used as a therapy for, and prophylaxis against, recurrent tumors in patients with carcinoma in situ (CIS) of the urinary bladder, and to prevent recurrence of Stage TaT1 papillary tumors of the bladder at high risk of recurrence
- BCG LIVE (TICE® BCG) is not a vaccine for the prevention of cancer
- Reconstituted TICE® BCG should be kept refrigerated (2-8° C), protected from exposure to direct sunlight, and used within 2 hours
- Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
|
